I’m excited to share a deeper look into my professional journey in oncology research, clinical development, and regulatory science. Over the past 30+ years, I’ve had the opportunity to work across global biopharma organizations, advisory boards, and academic institutions, all focused on advancing patient-centered innovation. Here is my biography.

I’m pleased to share a biography that reflects my journey as a global pharmaceutical and biotechnology executive across medical affairs, clinical development, regulatory strategy, and commercialization. Over the past three decades, I’ve had the opportunity to lead across respiratory, rare disease, oncology, endocrinology, infectious disease, and global market expansion while building teams, advancing innovation, and supporting product launches worldwide. Here is my biography.

I am excited to share a deeper look into my professional journey and the experiences that have shaped my passion for regulatory leadership, pharmaceutical innovation, and organizational integrity. Throughout my 45-year career, I have had the privilege of contributing to companies, teams, and missions that advance global health and patient safety. Here is my biography.

I am excited to share a comprehensive biography that reflects my journey across global medical affairs, digital health innovation, pharmaceutical leadership, and patient-centered impact. Throughout my career, I’ve been fortunate to build high-performing teams, pioneer digital health solutions, collaborate with exceptional partners, and help organizations transform the way they serve patients.

I’m proud to share a reflection of my professional journey—a story of curiosity, collaboration, and a lifelong passion for advancing medical innovation. Over the past 30 years, I’ve had the privilege of leading R&D operations, serving on multiple corporate boards, and mentoring teams across the global life sciences community. Here is my biography.

After over 35 years of experience in nursing, regulatory affairs, and clinical development, I’m excited to share a bit more about my professional journey. From leading global clinical trials to serving on school boards, I’ve remained passionate about improving patient outcomes and advancing healthcare innovation. Here is my biography.

I am proud to share my professional biography, which reflects over forty years of experience in the pharmaceutical, biotechnology, and contract research industries. My journey has taken me from scientific research to executive leadership, guiding organizations through growth, transformation, and innovation. I remain deeply committed to using my knowledge to help companies succeed and improve health outcomes worldwide.

Dr. Trudy Vanhove is a seasoned biopharmaceutical executive and venture partner with nearly 30 years of experience leading drug development, regulatory strategy, and corporate growth across biotech and pharmaceutical companies. She has played a pivotal role in launching multiple FDA- and EMA-approved therapies and has a strong track record in building high-performing teams, driving strategic partnerships, and supporting financing efforts. Fluent in several languages and with extensive international experience, Dr. Vanhove brings a unique global perspective and a deep scientific and business acumen to board roles and investment opportunities in the biotech sector.

I'm a global medical affairs leader with over two decades of experience spanning clinical research, regulatory strategy, and pharmaceutical innovation across Latin America and the United States. Throughout my career, I've had the privilege of guiding high-performing teams, launching impactful therapies, and aligning regional execution with global vision—most recently as Head of Medical Affairs for Emerging Therapy Areas at Novo Nordisk. Passionate about advancing patient outcomes and fostering collaborative leadership, I bring a strategic, people-centered approach to everything I do in the healthcare space.

I’m a pharmacist and consultant with over 25 years of experience spanning the pharmaceutical industry, regulatory affairs, and academia. My career has been driven by a passion for translating complex regulatory requirements into clear, actionable strategies that help companies innovate responsibly. Through leadership roles in both industry and consulting, I’ve had the privilege of mentoring professionals, teaching at top pharmacy schools, and partnering with organizations to align science, compliance, and strategic growth. I’m always excited to connect with others who are committed to elevating healthcare and advancing thoughtful, compliant innovation.

I’m a seasoned clinical research professional with over two decades of experience supporting and leading clinical trials across all phases and therapeutic areas. My journey has taken me through top pharmaceutical organizations like Bristol Myers Squibb, GSK, Karuna Therapeutics, and AstraZeneca, where I’ve specialized in clinical operations, regulatory compliance, and team development. I’m passionate about building efficient systems, mentoring others, and contributing to work that ultimately improves patient lives.

I'm a biotech executive and scientist with a passion for advancing oncology therapeutics from discovery through clinical development. Over the course of my career, I’ve led R\&D strategy and operations in organizations ranging from early-stage startups to large global pharma, including Takeda, ImmunoGen, Novartis, and Biogen. I’ve had the privilege of building high-performing teams, guiding complex portfolios, and contributing to therapies that make a real difference for patients. Today, I enjoy advising innovative biotech companies and VCs as they shape the next generation of cancer treatments.

Susan Essumang is a seasoned clinical operations executive who merges scientific rigor with strategic leadership to drive high-impact pharmaceutical and biotech programs. Known for her patient-centric approach, Susan has led the development and regulatory success of globally recognized treatments, including Victoza®, Ozempic®, and Wegovy®, delivering billions in projected revenue. Her ability to align enterprise objectives with operational excellence has resulted in accelerated trial timelines, significant cost savings, and flawless regulatory inspections. With deep therapeutic expertise, a foundation in neuroscience and healthcare administration, and a commitment to innovation, Susan continues to shape the future of clinical research through data-driven insights and strategic execution.

I’m excited to share a professional biography that reflects my journey across the biotech and pharma industries—from hands-on research to strategic leadership. It's been a privilege to work with exceptional teams, lead impactful projects, and help bring new therapies closer to the patients who need them most.

I'm excited to share my professional biography, capturing the journey I've taken across HEOR, pharmaceutical innovation, real-world evidence, and health policy. With over 20 years of experience in building value through data, strategic insight, and collaborative leadership, I'm proud to continue this work alongside inspiring teams and partners.

Dr. Michael E. Kuligowski, MD, PhD, MBA, is a globally recognized physician-executive with over four decades of leadership in dermatology, clinical development, and pharmaceutical strategy. With a distinguished career spanning Europe and the United States, he has led the development and approval of numerous dermatologic therapies, including Opzelura® for atopic dermatitis and vitiligo. Known for his scientific rigor, strategic foresight, and collaborative leadership, Dr. Kuligowski continues to influence the future of dermatologic innovation through executive roles, advisory board appointments, and pro-bono consulting in the life sciences sector.